You are here


Original articles

Pestka J.M., Zeisel M.B., Bläser E., Schürmann P., Bartosch B., Cosset F.L., Patel H., Meisel H., Baumert J., Viazov S., Rispeter K., Blum H.E., Roggendorf M., Baumert T.F. Rapid induction of virus neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C. Proc. Natl. Acad. Sci. USA, 2007, 104, 6025-6030.

Baumert T.F., Rosler C., Malim M., Weizsacker F. Hepatitis B virus DNA is subject to extensive editing by the human deaminase APOBEC 3C. Hepatology, 2007, 46, 682-689.

Lucas M., Ulsenheimer A., Pfafferot G., Heeg M.H.J., Gaudieri S., Gruner N., Rauch A., Gerlach J.T., Jung M.C., Zachoval R., Pape G.R., Santantonio T., Nitschko H., Obermeier M., Phillips R., Scriba T.J., Semmo N., Day C., Weber J.N., Fidler S., Thimme R., Haberstroh A., Baumert T.F., Klenerman P., Diepolder H.M. Tracking virus-specific CD4+ T cells during and after acute hepatitis C virus infection. PLoS ONE, 2007, Jul 25, 2:e649.

Schvoerer E., Soulier E., Royer C., Renaudin A.C., Thumann C., Fafi-Kremer S., Brignon N., Doridot S., Meyer N., Ellero B., Woehl-Jaegle M.L., Meyer C., Wolf P., Zachary P., Baumert T.F., Stoll-Keller F. Early evolution of hepatitis C virus (HCV) quasispecies after liver transplant for HCV-related disease. J. Infect. Dis., 2007, 196, 528-536.

Elmowalid G., Qiao M., Jeong S., Baumert T.F., Sapp R., Hu Z., Murthy K., Liang T.J. Immunization with hepatitis C virus-like particles results in control of hepatitis C virus infection in chimpanzees. Proc. Natl. Acad. Sci. USA, 2007, 104, 8427-32.

Kapadia S.B., Barth H., Baumert T.F., Mckeating J.A., Chisari F.V. Initiation of hepatitis C virus infection is dependent on cholesterol and cooperativity between CD81 and scavenger receptor B type I. J. Virol., 2007, 81, 374-383.

Zeisel M.B., Koutsoudakis G., Schnober E.K., Haberstroh A., Blum H.E., Cosset F.L., Wakita T., Jaeck D., Doffoel M., Royer C., Soulier E., Schvoerer E., Schuster C., Stoll-Keller F., Pietschmann T., Bartenschlager R., Barth H., Baumert T.F. Scavenger receptor class B type I is a key host factor for hepatitis C virus required for an entry step closely linked to CD81. Hepatology, 2007, 46, 1722-1731.

Akazawa D., Date T., Morikawa K., Murayama A., Miyamoto M., Kaga M., Barth H., Baumert T.F., Dubuisson J., Wakita T. CD81 expression is important for the permissiveness of Huh7 cell clones for heterogeneous hepatitis C virus infection. J. Virol., 2007, 81, 5036-45.

Ballout M., Germi R., Fafi-Kremer S., Guimet J., Bargues G., Seigneurin J.M., Morand P. Real-time quantitative PCR for assessment of antiviral drug effets against Epstein-Barr virus replication and EBV late mRNA expression. J. Virol. Methods, 2007, 143, 38-44.

Payan C., Pivert A., Morand P., Fafi-Kremer S., Carrat F., Pol S., Cacoub P., Perronne C., Lunel F., ANRS HC02 RIBAVIC study team. Rapid and early virological response to chronic hepatitis C treatment with IFN alpha2b or PEG-IFN alpha2b plus ribavirin in HIV/HCV co-infected patients. Gut, 2007, 58, 1111-1116.

Dimitrova M., Arntz Y., Lavalle P., Meyer F., Wolf M., Schuster C., Haikel Y., Voegel J.C., Ogier J. Adenoviral gene delivery from multilayered polyelectrolyte architectures. Adv. Funct. Mat., 2007, 17, 233-245.

Lapierre V., Auperin A., Robinet E., Ferrand C., Oubouzar N., Tramalloni D., Saas P., Debaene B., Lasser P., Tiberghien P. Immune modulation and microchimerism after unmodified versus leukoreduced allogeneic red blood cell transfusion in cancer patients: results of a randomized study. Transfusion, 2007, 47, 1691-1699.

Nousbaum J.B., Cadranel J.F., Nahon P., Khac E.N., Moreau R., Thevenot T., Silvain C., Bureau C., Nouel O., Pilette C., Paupard T., Vanbiervliet G., Oberti F., Davion T., Jouannaud V., Roche B., Bernard P.H., Beaulieu S., Danne O., Thabut D., Chagneau-Derrode C., De Ledinghen V., Mathurin P., Pauwels A., Bronowicki J.P., Habersetzer F., Abergel A., Audigier J.C., Sapey T., Grange J.D., Tran A. Club Francophone pour l’Etude de l’Hypertension Portale ; Association Nationale des Hépato-Gastroentérologues des Hôpitaux Généraux de France. Diagnostic accuracy of the Multistix 8 SG reagent strip in diagnosis of spontaneous bacterial peritonitis. Hepatology, 2007, 45, 1275-81.

Deschamps M., Mercier P., Certoux J.M., Henry C., Lioure B., Pagneux C., Cahn J.Y., Deconinck E., Tiberghien P., Robinet E., Ferrand C. Deletions within the HSV-tk transgene in long-lasting circulating gene-modified T-cells infused with a hematopoietic graft. Blood, 2007, 110, 3842-52. ;

Dumortier J., Mekki Y., Rimmele T., Ber C., Maillard E., Fafi-Kremer S., Lina B., Scoazec J.Y., Delafosse B., Boillot O. EBV-induced fulminant hepatic failure: favourable outcome after liver transplantation. Gastroenterol. Clin. Biol., 2007., 31, 725-8.

Laperche S., Bouchardeau F., Thibault V., Pozzeto B., Vallet S., Rosenberg A.R., Roque-Afonso A.M., Gassin M., Stoll-Keller F., Trimoulet P., Gault E., Chanzy B., Mercier B., Branger M., Pawlotsky J.M., Henquell C., Lunel F., Gaudy-Graffin C., Alain S., Chaix M.L., Duverlie G., Izopet J., Lefrere J.J. Multi-center trials need to use the same assay for hepatitis C virus (HCV) viral load determination. J. Clin. Microbiol., 2007, 45, 3788-90.

Shiffman M.L., Suter F., Bacon B.R., Nelson D., Harley H., Sola R., Shafran S.D., Barange K., Lin A., Soman A., Zeuzem S., Crawford D., Leggett L., Roberts S., Weltman M., Greenbloom S., Menon K., Bourliere M., Brissot P., Bronowicki J.P., Doffoel M., Hezode C., Marcellin P., Tran A., Zarski J.P., Avci O., Berg T., Potthoff O., Rasenack J., Ross O., Von Wagner M., Ascione A., Brillanti S., Brunetto M., Bruno R., Bruno S., Cane E., Aguilar J., Barcena R., Diago M., Enriquez J., Garcia-Samaniego J., Moreno R., Planas R., Rincon D., Sola R., Testillano M., Anand B., Bilir B.B., Balan V., Bank L., Barranco E., Berg C., Bernstein D., Bloom J., Bonkovsky H., Box T., Brau N., Bzowej N., Cassidy W., Clain D., Corasanti J., Davis M., Dejesus E., Delich P., Esposito S., Etzkorn K., Flora K., Fried M., Fromm H., Ghalib R., Gibas A., Godofsky E., Gompf S., Gordon S., Gordon F., Hammond G., Harrison S., Herrera J., Ho S., Howell C., Joshi S., Keeffe E., Kranz K., Kwo P., Lake-Bakaar G., Larson A., Levin A., Lok A., Lucey M., Lyons M., Malet P., Malik P., Manch R., Mehra S., Mihas A., Mikolich D., Morgan T., Muir A., Nguyen R., Nunes D., Nyberg L., O'brien C., Pappas S., Pauly M., Pedrosa M., Perkel M., Person J., Pockros P., Post A., Poulos J., Powell R., Raj V., Reed A., Reindollar R., Riley T., Rodriguez-Torres M., Rubin R., Sahagun G., Schmidt W., Sepe T., Shaw-Stiffel T., Sheikh A., Sherman K., Smith C., Stevens D., Sulkowski M., Toro D., Torres E., Tran T., Tsai N., Wohlman R., Wright W., Wruble L., Younossi Z. Peginterferon alfa-2a and ribavirin for 16 or 24 weeks in HCV genotype 2 or 3. N. Engl. J. Med., 2007, 357, 124-34.

Blanc T., Cortes A., Goere D., Sibert A., Pessaux P., Beghiti J., Sauvanet A. Hemorrhage after pancreaticoduodenectomy: when is surgery still indicated? Am. J. Surg., 2007, 194, 3-9.

Brachet D., Mucci S., Desolneux G., Leboulanger G., Amie F., Pessaux P., Arnaud J.P. The simultaneous occurence of mucinous cystadenomas in liver and pancreas. Eur. J. Gastroenterol. Hepatol., 2007, 19, 801-4.

Lermite E., Pessaux P., Brehant O., Teyssedou C., Pelletier I., Etienne S., Arnaud J.P. Risk factors of pancreatic fistula and delayed gastric emptying after pancreaticoduodenectomy with pancreaticogastrostomy. J. Am. Coll. Surg., 2007, 204, 588-96.

Lermitte E., Regenet N., Tuech J.J., Pessaux P., Meurette G., Bridoux V., Aube C., Arnaud J.P. Diagnosis and treatment of hemosuccus pancreaticus : development of endovascular management. Pancreas, 2007, 34, 229-32.

Mucci-Hennekinne S., Brachet D., Clouston H., Pessaux P., Hamy A., Arnaud J.P. Management of a stenotic pancreatico-digestive tract anastomosis following pancreatoduodenectomy. J. Hepatobiliary Pancreat. Surg., 2007, 14, 514-7.

Holl V., Schmidt S., Aubertin A.M., Moog C. The major population of PHA-stimulated PBMC infected by R5 or X4 HIV variants after a single cycle of infection is predominantly composed of CD45RO(+)CD4 (+) T lymphocytes. Arch of Virol, 2007, 152, 507-518.

Reviews, editorials etc.

Baumert T.F., Thimme R., von Weizsacker F. Pathogenesis of hepatitis B virus infection. World J Gastroenterol., 2007, 13, 82-90.

Zeisel M.B., Fafi-Kremer S., Fofana I., Barth H., Stoll-Keller F., Doffoël M., Baumert T.F. Neutralizing antibodies in hepatitis C virus infection. World J. Gastroenterol., 2007, 13, 4824-4830.

Fischer R., Baumert T.F., Blum H.E. Hepatitis C virus infection and apoptosis. World J. Gastroenterol., 2007, 13, 4865-4872.

Jaeck D., Pessaux P., Wolf P. Which  types of graft to use in patients with acute liver failure? J. Hepatol., 2007, 46, 570-3.

Fafi-Kremer S., Morand P., Seigneurin J.M. La mononucléose infectieuse revisitée. Virologie, 2007, 11, 13-26.

Gaspard P., Mosnier A., Cohen J.M., Gunther D., Quintle F., Eschbach E., Schwindenhammer R., Stoll-Keller F., Gayet S. Respiratory tract infections in institutions for elderly people : the GROG Géronto-Alsace, strategy of surveillance and alert. Med. Mal. Infect., 2007, 37 (Suppl 3), S215-22.

Lupberger J., Hildt E. Hepatitis B virus-induced oncogenesis. World J. Gastroenterol., 2007, 13, 74-81.

Arntz Y., Ball V., Benkirane-Jessel N., Boulmedais F., Debry C., Dimitrova M., Elkaim R., Haikel Y., Hemmerle J., Lavalle P., Meyer F., Muller S., Ogier J., Schaaf P., Senger B., Stanic V., Tenenbaum H., Vautier D., Vodouhe C., Volodkin D., Voegel J.C., Werner S. Polymers in biomaterials science: from surface functionalisation to tissue engineering. Actualité Chimique, 2007, 310, 20-31.

Fafi-Kremer S., Schvoerer E., Wolf P., Habersetzer F., Doffoel M., Baumert T.F., Stoll-Keller F. Recurrent hepatitis C virus infection after liver transplantation. Current Topics in Virology, 2007, 6, 47-52.

Zeisel M.B., Baumert T.F. Molecular mechanisms of hepatitis C virus entry – Impact of host entry factors of initiation of infection. In: „Genes, Genomes and Genomics, volume three“. (D. Thangadurai, W. Tang, T. Pullaiah eds.), Regency Publications, New Delhi, 2007.

Zarski J.P., Bedossa P., Bronowicki J.P., Doffoel M., Poynard T. Non invasive markers using for the assessment of fibrosis in hepatitis C. Gastroenterol. Clin. Biol., 2007, 31, S34-9.